Drug intelligence / Profile preview

N-(1-isopropylpiperidin-4-yl)-1-(3-methoxybenzyl)-1H-indole-2-carboxamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

N-(1-isopropylpiperidin‑4‑yl)‑1‑(3‑methoxybenzyl)‑1H‑indole‑2‑carboxamide is a synthetic small molecule compound with the molecular formula C25H31N3O2 and a molecular weight of approximately 405.5 g/mol[2][9][3]. It is primarily referenced in chemical and pharmacological databases as an experimental or research compound, not as an approved pharmaceutical agent. The compound has been studied for its binding affinity to coagulation factor X, with reported Ki values in the nanomolar range, suggesting it may act as an inhibitor of this serine protease involved in the blood coagulation cascade[5][2][3]. No clinical development or therapeutic indication has been established for this molecule.

Other names
1-[(3-methoxyphenyl)methyl]-N-[1-(propan-2-yl)piperidin-4-yl]-1H-indole-2-carboxamide1-(3-methoxy-benzyl)-1H-indole–2-carboxylic acid (1-isopropyl-piperidin–4–yl)–amide
02

Targets

F10 (Factor Xa)

Beyond the preview

Go deeper on N-(1-isopropylpiperidin-4-yl)-1-(3-methoxybenzyl)-1H-indole-2-carboxamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-(1-isopropylpiperidin-4-yl)-1-(3-methoxybenzyl)-1H-indole-2-carboxamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call